The Experts below are selected from a list of 1542 Experts worldwide ranked by ideXlab platform
Jiao Wei - One of the best experts on this subject based on the ideXlab platform.
-
The Influences of Different Exercises on Adolescent Primary Dysmenorrea Symptom and Uterus Blood Flow
Journal of Beijing Sport University, 2007Co-Authors: Jiao WeiAbstract:Primary dysmenorrhea(PD) is a common gynecology disease to adolescent girls,so the purpose of this article is to study the influences of adolescent primary dysmenorrea symptom and Uterus Blood Flow with different methods of exercises.The study shows as follows.The indexes of A/B,RI,and PI of PD girls are significantly higher than those of no-dysmenorrhea girls.PD girls' Uterus Blood Flow is bad and their Uteruses are short of Blood and oxygen,so they feel uncomfortable.Aerobic exercises have good effects on dysmenorrheal,obviously improve the indexes of A/B,RI,and PI,effectively improve the Uterus Blood Flow,and relieve the dysmenorrea symptom.12 weeks aerobic exercises of middle intensity treat light and middle dysmenorrea better.Both systemic-exercises and local-exercises can improve the Uterus Blood Flow well,but local-exercises relieve dysmenorrhea symptom better.
R.c. Rudigoz - One of the best experts on this subject based on the ideXlab platform.
-
Uterus and endometrium: Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero
Human reproduction (Oxford England), 1996Co-Authors: B. Salle, P. Sergeant, A. Awada, V. Bied-damon, P. Gaucherand, C. Boisson, S. Guibaud, M. Benchaib, R.c. RudigozAbstract:The aim of this prospective study was to establish complementary data of uteri exposed to diethylstilbestrol (DES) in utero for transvaginal analysis and vascularity changes during the menstrual cycle. A total of 28 women with DES-exposed uteri were compared with 60 non-exposed women. Transvaginal ultrasound and colour Doppler imaging were performed on days 5 and 22 of the menstrual cycle. Uteri were measured on sagittal and transverse scans. Uterine length, width, thickness and uterine cavity length and width were measured. Uterine volume and uterine cavity area were calculated. DES-exposed uterine volume was equal to 31.84 +/- 3.37 cm3. The cavity area of DES-exposed Uterus was equal to 35.85 +/- 3.93 cm2. Cervix length of DES-exposed Uterus was significantly smaller than that of non-exposed Uterus. The uterine artery pulsatility index (PI) of DES-exposed Uterus was significantly higher than that of normal Uterus. Blood Flow remained stable throughout the menstrual cycle. The PI of DES-exposed Uterus remained stable during the menstrual cycle, as in non-exposed Uterus, and it decreased during the luteal phase. This lack of modification in vascularity of DES-exposed Uterus may explain miscarriages and obstetric complications such as intrauterine growth retardation or pre-eclampsia. The data may have implications for the assessment of reproductive status and the design of future studies on disorders of implantation in DES-exposed Uterus.
B. Salle - One of the best experts on this subject based on the ideXlab platform.
-
Uterus and endometrium: Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero
Human reproduction (Oxford England), 1996Co-Authors: B. Salle, P. Sergeant, A. Awada, V. Bied-damon, P. Gaucherand, C. Boisson, S. Guibaud, M. Benchaib, R.c. RudigozAbstract:The aim of this prospective study was to establish complementary data of uteri exposed to diethylstilbestrol (DES) in utero for transvaginal analysis and vascularity changes during the menstrual cycle. A total of 28 women with DES-exposed uteri were compared with 60 non-exposed women. Transvaginal ultrasound and colour Doppler imaging were performed on days 5 and 22 of the menstrual cycle. Uteri were measured on sagittal and transverse scans. Uterine length, width, thickness and uterine cavity length and width were measured. Uterine volume and uterine cavity area were calculated. DES-exposed uterine volume was equal to 31.84 +/- 3.37 cm3. The cavity area of DES-exposed Uterus was equal to 35.85 +/- 3.93 cm2. Cervix length of DES-exposed Uterus was significantly smaller than that of non-exposed Uterus. The uterine artery pulsatility index (PI) of DES-exposed Uterus was significantly higher than that of normal Uterus. Blood Flow remained stable throughout the menstrual cycle. The PI of DES-exposed Uterus remained stable during the menstrual cycle, as in non-exposed Uterus, and it decreased during the luteal phase. This lack of modification in vascularity of DES-exposed Uterus may explain miscarriages and obstetric complications such as intrauterine growth retardation or pre-eclampsia. The data may have implications for the assessment of reproductive status and the design of future studies on disorders of implantation in DES-exposed Uterus.
Buhler - One of the best experts on this subject based on the ideXlab platform.
-
In Process Citation
Zentralblatt fur Gynakologie, 1999Co-Authors: BuhlerAbstract:GnRH agonist (GnRHa) administered for 6 months leads to an effective desensitisation of the pituitary and hypoestrogenism without exerting a particular effect on the whole metabolism. At the end of the first month's a suppression of the serum estradiol levels are achieved, the level of LH and FSH decline in the hypogonadotropic range. No negative influence on the lipid metabolism after administration of GnRH agonist has been observed. The balance of HDL/LDL does not change during the treatment. There were neither any negative changes in the liver metabolism, kidney function nor in the electrolyte values. In anaemic premenopausal women, for example due to serious menstrual problems, a normalisation of the haemoglobin concentration is obtainable already after a 12-week treatment. With regard to the hemostatis system a significant reduction of the procoagulant activity, fibrin turnover rate and a significant improvement of fibrinolytic activity can be observed under a GnRHa therapy. Although the use of GnRHa leads without doubt to a drastic reduction in the Uterus Blood Flow there are no signs that this also leads to a change in the cerebral arteries Blood Flow. Menstrual bleeding occurs on average 3 months after the last injection of an GnRHa depot injection; with daily injection or nasal spray 3 to 4 weeks earlier. Theoretical considerations as well as the world-wide use as part of the infertility treatment--in some countries more than 90% of all IVF-cycles are performed using GnRH--,contradict the fact that GnRHa cause a teratogenic effect. Domineering undesirable side-effects during a treatment with GnRH can be traced back almost exclusively to the effective hormonal deprivation. In this context it is remarkable which percentage patients complain about trouble of this spectrum before GnRHa treatment is initiated. The chronicle reduction of the sexual hormone level leads without a doubt to a reduction of bone mineral density. The clinical relevance is furthermore a matter of controversial discussion. Prevention measures can be undertaken through an add-back therapy. This can also be of help in the case of vegetative side-effects caused by a decrease in sexual hormones. The question arises to what extent effective non hormonal add-back therapies are at disposal in the treatment of sexual hormone related malignant tumours. Also men with testosterone deprivation can suffer from distinctive hot flushes, sleeping disturbances and depression which requires some kind of relief in order to maintain an acceptable quality of life.
P. Sergeant - One of the best experts on this subject based on the ideXlab platform.
-
Uterus and endometrium: Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero
Human reproduction (Oxford England), 1996Co-Authors: B. Salle, P. Sergeant, A. Awada, V. Bied-damon, P. Gaucherand, C. Boisson, S. Guibaud, M. Benchaib, R.c. RudigozAbstract:The aim of this prospective study was to establish complementary data of uteri exposed to diethylstilbestrol (DES) in utero for transvaginal analysis and vascularity changes during the menstrual cycle. A total of 28 women with DES-exposed uteri were compared with 60 non-exposed women. Transvaginal ultrasound and colour Doppler imaging were performed on days 5 and 22 of the menstrual cycle. Uteri were measured on sagittal and transverse scans. Uterine length, width, thickness and uterine cavity length and width were measured. Uterine volume and uterine cavity area were calculated. DES-exposed uterine volume was equal to 31.84 +/- 3.37 cm3. The cavity area of DES-exposed Uterus was equal to 35.85 +/- 3.93 cm2. Cervix length of DES-exposed Uterus was significantly smaller than that of non-exposed Uterus. The uterine artery pulsatility index (PI) of DES-exposed Uterus was significantly higher than that of normal Uterus. Blood Flow remained stable throughout the menstrual cycle. The PI of DES-exposed Uterus remained stable during the menstrual cycle, as in non-exposed Uterus, and it decreased during the luteal phase. This lack of modification in vascularity of DES-exposed Uterus may explain miscarriages and obstetric complications such as intrauterine growth retardation or pre-eclampsia. The data may have implications for the assessment of reproductive status and the design of future studies on disorders of implantation in DES-exposed Uterus.
